- Home
- MAIA vs SNAL Comparison
MAIA vs SNAL Comparison
Compare MAIA & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- SNAL
- Stock Information
- Founded
- MAIA 2018
- SNAL 2000
- Country
- MAIA United States
- SNAL United States
- Employees
- MAIA N/A
- SNAL N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- SNAL Computer Software: Prepackaged Software
- Sector
- MAIA Health Care
- SNAL Technology
- Exchange
- MAIA Nasdaq
- SNAL Nasdaq
- Market Cap
- MAIA 44.9M
- SNAL 45.1M
- IPO Year
- MAIA 2022
- SNAL 2022
- Fundamental
- Price
- MAIA $1.11
- SNAL $1.00
- Analyst Decision
- MAIA
- SNAL
- Analyst Count
- MAIA 0
- SNAL 0
- Target Price
- MAIA N/A
- SNAL N/A
- AVG Volume (30 Days)
- MAIA 747.3K
- SNAL 58.1K
- Earning Date
- MAIA 11-07-2025
- SNAL 11-13-2025
- Dividend Yield
- MAIA N/A
- SNAL N/A
- EPS Growth
- MAIA N/A
- SNAL N/A
- EPS
- MAIA N/A
- SNAL N/A
- Revenue
- MAIA N/A
- SNAL $91,041,290.00
- Revenue This Year
- MAIA N/A
- SNAL $13.87
- Revenue Next Year
- MAIA N/A
- SNAL $26.20
- P/E Ratio
- MAIA N/A
- SNAL N/A
- Revenue Growth
- MAIA N/A
- SNAL 24.25
- 52 Week Low
- MAIA $1.05
- SNAL $0.64
- 52 Week High
- MAIA $3.48
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- MAIA 34.52
- SNAL 45.37
- Support Level
- MAIA $1.05
- SNAL $0.96
- Resistance Level
- MAIA $1.35
- SNAL $1.05
- Average True Range (ATR)
- MAIA 0.10
- SNAL 0.07
- MACD
- MAIA -0.03
- SNAL -0.01
- Stochastic Oscillator
- MAIA 12.85
- SNAL 16.58
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.